Emcure Pharmaceuticals Limited (NSE:EMCURE)
India · Delayed Price · Currency is INR 1,365.40
+11.10 (0.82%)
Last updated: Sep 9, 2025, 10:24 AM IST
Emcure Pharmaceuticals Company Description
Emcure Pharmaceuticals Limited provide quality and affordable healthcare solutions worldwide.
It offers products in various therapeutic areas, such gynecology, anti-infectives, pain/analgesics, Vitamins, Minerals & Nutrients, blood-related, oncology, respiratory, HIV antivirals, gastro, anti-diabetic, neuro, and cardiovascular.
It provides its products under Orofer XT, Tenectase, Pause, Metpure XL, Vylda, Vitanova, and Proxym brand names.
Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.
Emcure Pharmaceuticals Limited
| Country | India |
| Founded | 1981 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6,731 |
| CEO | Satish Mehta |
Contact Details
Address: Plot No. P-1 and P-2 Pune, Maharashtra 411057 India | |
| Phone | 91 20 3507 0033 |
| Website | emcure.com |
Stock Details
| Ticker Symbol | EMCURE |
| Exchange | National Stock Exchange of India |
| Fiscal Year | April - March |
| Reporting Currency | INR |
| ISIN Number | INE168P01015 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Satish Ramanlal Mehta | Chief Executive Officer, MD and Executive Director |
| Samit Satish Mehta | President of Operations and Whole-Time Director |
| Dr. Mukund Keshao Gurjar | Chief Scientific Officer and Whole-Time Director |
| Sunil Rajanikant Mehta | Executive Director of Projects and Whole-Time Director |
| Namita Vikas Thapar | Executive Director of India Business and Whole-Time Director |
| Tajuddin Sabir Shaikh | Chief Financial Officer |
| Chetan Rajendra Sharma | Company Secretary and Compliance Officer |
| Naveen Soni | Director of Corporate Communications and Public Relations |
| Vikas Madan Thapar | President of Corporate Development, Strategy and Finance |
| Rajesh Nair | President of Human Resources |